COYA

2.9501.01%
AT

Aaron Thome

Head of Neuroinflammation Platform

Mr. Aaron Thome, Ph.D. is Head of Neuroinflammation Platform of Coya Therapeutics, Inc. He retains his position as Assistant Research Professor in the Department of Neurology at the Houston Methodist Neurological Institute, Johnson Center for Cellular Therapeutics, working closely with Dr. Stanley Appel, who is renowned for his discovery of Tregs as a treatment for inflammation in neurodegenerative diseases. His transformational work includes elucidating neuroinflammatory mechanisms of neurodegenerative disease (ALS, Alzheimer’s, Parkinson’s, etc.) and developing therapeutic approaches to modulate or halt the progression of these devastating diseases. He completed his postdoctoral training with Dr. Appel at the Houston Methodist Neurological Institute, having received his Ph.D. from the University of Alabama at Birmingham at the Center for Neurodegeneration and Experimental Therapeutics. He received his B.S. in Biomedical Science from Texas A&M University.

Positions